RARA and acute promyelocytic leukemia: ATRA causes a conformational change of the PML–RARA fusion transcripts, leading to the release of the co-repressors, recruitment of histone acetyltransferases, and relief of transcriptional repression, which causes the treated APL cells to undergo terminal myeloid differentiation and finally apoptosis [12].